Adenocarcinoma, Bronchiolo-Alveolar - 30 Studies Found

Completed : Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma
: Adenocarcinoma, Bronchiolo-Alveolar
: 2006-10-05
:
  • Drug: erlotinib Erlotinib 150

Terminated : VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features
:
  • Carcinoma, Non-Small-Cell Lung
  • Adenocarcinoma, Bronchiolo-Alveolar : 2005-06-30
    : Drug: VELCADE
Recruiting : Telomere Biology in Early Adenocarcinoma of the Lung
:
  • Adenocarcinoma of the Lung
  • Adenocarcinoma, Bronchiolo-Alveolar<
    : 2014-09-10
Active, not recruiting : S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
: Lung Cancer
: 2007-02-15
:
  • Biological: bevacizumab
  • Drug: erlotinib hy
Completed : Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
:
  • Bronchoalveolar Cell Lung Cancer
  • Recurrent Non-small Cell Lung
    : 2002-01-04
    :
    • Drug: gefitinib Given orally
Completed : First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
:
  • Lung Neoplasms
  • Non-Small Cell Lung Cancer
  • Adenocarcinoma of the Lung
  • Bronchoalveolar Cell Lung Cancer : 2005-07-08
    : Drug: bortezomib Given IV
Completed : Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma
:
  • Lung Cancer
  • Adenocarcinoma

: 2007-01-30
: Drug: sunitinib 50mg po qd x 4 weeks on followed by 2 weeks off for a 6 week cycle.
Completed : Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
: Lung Cancer
: 1999-11-01
:
  • Drug: antineoplaston A10
  • Drug: antineoplas
Next >>>